Alkane activation by P450 oxygenases

References

• Asperger O, Naumann A, Kleber HP. Occurrence of cytochrome P450 in Acinetobacter strains after growth on n-hexadecane. FEMS Microbiol Lett 1981; 11: 309–312
   Google Scholar
• Ayala M, Torres E. Enzymatic activation of alkanes: Constraints and prospective. Appl Catal A 2004; 272: 1–13
   Google Scholar
• Bell SG, Stevenson JA, Boyd HD, Campbell S, Riddle AD, Orton EL, Wong LL. Butane and propane oxidation by engineered cytochrome P450(cam). Chem Commun 2002; 2002: 490–491
   Google Scholar
• Bell SG, Orton E, Boyd H, Stevenson J-A, Riddle A, Campbell S, Wong L-L. Engineering cytochrome P450cam into an alkane hydroxylase. Dalton Trans 2003; 2003: 2133–2140
   Google Scholar
• Bernauer U, Glatt H, Heinrich-Hirsch B, Liu Y, Muckel E, Vieth B, Gundert-Remy U. Heterologous expression of mouse cytochrome P450 2E1 in V79 cells: Construction and characterization of the cell line and comparison with V79 cell lines stably expressing rat P450 2E1 and human P450 2E1. Altern Lab Anim 2003; 31: 21–30
   PubMedGoogle Scholar
• Bolt HM, Roos PH, Thier R. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: Consequences for occupational and environmental medicine. Int Arch Occup Environ Health 2003; 76: 174–185
   PubMed Web of Science ®Google Scholar
• Budde M, Maurer SC, Schmid RD, Urlacher VB. Cloning, expression and characterisation of CYP102A2, a self-sufficient P450 monooxygenase from Bacillus subtilis. Appl Microbiol Biotechnol 2004; 66: 180–186
   PubMedGoogle Scholar
• Carr BA, Ramakanth S, Dannan GA, Yost GS. Characterization of pulmonary CYP4B2, specific catalyst of methyl oxidation of 3-methylindole. Mol Pharmacol 2003; 63: 1137–1147
   PubMed Web of Science ®Google Scholar
• Celik A, Speight RE, Turner NJ. 2005. Identification of broad specificity P450CAM variants by primary screening against indole as substrate. Chem Commun 3652–3654.
   Google Scholar
• Chang D. 2003. Regio- and stereoselective hydroxylations with Sphingomonas sp. HXN-200 [dissertation]. Zürich: Swiss Federal Institute of Technology. 279 p.
   Google Scholar
• Cheesman MJ, Baer BR, Zheng YM, Gillam EMJ, Rettie AE. Rabbit CYP4B1 engineered for high-level expression in Escherichia coli: Ligand stabilization and processing of the N-terminus and heme prosthetic group. Arch Biochem Biophys 2003; 416: 17–24
   PubMedGoogle Scholar
• Chen XH, Christopher A, Jones JP, Bell SG, Guo Q, Xu F, Rao ZH, Wong LL. Crystal structure of the F87W/Y96F/V247L mutant of cytochrome P-450cam with 1,3,5-trichlorobenzene bound and further protein engineering for the oxidation of pentachlorobenzene and hexachlorobenzene. J Biol Chem 2002; 277: 37519–37526
   PubMed Web of Science ®Google Scholar
• Cheng D, Kelley RW, Cawley GF, Backes WL. High-level expression of recombinant rabbit cytochrome P450 2E1 in Escherichia coli C41 and its purification. Prot Exp Purif 2004; 33: 66–71
   PubMedGoogle Scholar
• Cryle MJ, Stok JE, De Voss JJ. Reactions catalyzed by bacterial cytochromes P450. Australian J Chem 2003; 56: 749–762
   Google Scholar
• Del Carratore MR, Mezzatesta C, Hidestrand M, Neve P, Amato G, Gervasi PG. Cloning and expression of rat CYP2E1 in Saccharomyces cerevisiae: Detection of genotoxicity of N-alkylformamides. Environ Mol Mutagen 2000; 36: 97–104
   PubMedGoogle Scholar
• Denisov IG, Makris TM, Sligar SG, Schlichting I. Structure and chemistry of Cytochrome P450. Chem Rev 2005; 105: 2253–2278
   PubMed Web of Science ®Google Scholar
• Duetz WA, van Beilen JB, Witholt B. Using proteins in their natural environment: Potential and limitations of microbial whole-cell hydroxylations in applied biocatalysis. Curr Opin Biotechnol 2001; 12: 419–425
   Google Scholar
• Duetz WA, Witholt B, Jourdat C. 2002. Microbial biotransformation process for the preparation of perillyl alcohol. WO 2002066662.
   Google Scholar
• England PA, Harford CCF, Stevenson JA, Rouch DA, Wong LL. The oxidation of naphthalene and pyrene by cytochrome P450cam. FEBS Lett 1998; 424: 271–274
   PubMedGoogle Scholar
• Fairhead M, Giannini S, Gillam EMJ, Gilardi G. Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego. J Biol Inorg Chem 2005; 10: 842–853
   PubMedGoogle Scholar
• Fickers P, Benetti PH, Wache Y, Marty A, Mauersberger S, Smit MS, Nicaud JM. Hydrophobic substrate utilisation by the yeast Yarrowia lipolytica, and its potential applications. FEMS Yeast Res 2005; 5: 527–543
   PubMed Web of Science ®Google Scholar
• Filipovic D, Paulsen MD, Loida PJ, Sligar SG, Ornstein RL. Ethylbenzene hydroxylation by cytochrome P450cam. Biochem Biophys Res Commun 1992; 189: 488–495
   PubMedGoogle Scholar
• Fisher MB, Zheng Y-M, Rettie AE. Positional specificity of rabbit CYP4B1 for ω-hydroxylation of short–medium chain fatty acids and hydrocarbons. Biochem Biophys Res Commun 1998; 248: 352–355
   PubMed Web of Science ®Google Scholar
• Fuji T, Narikawa T, Sumisa F, Arisawa A, Takeda K, Kato J. Production of α,ω-alkanediols using Escherichia coli expressing a cytochrome P450 from Acinetobacter sp. OC4. Biosci Biotechnol Biochem 2006; 70: 1379–1385
   PubMedGoogle Scholar
• Funhoff EG, Bauer U, Garcia RI, Witholt B, van Beilen JB. CYP153A6, a soluble P450 oxygenase catalyzing terminal-alkane hydroxylation. J Bacteriol 2006; 188: 5220–5227
   PubMed Web of Science ®Google Scholar
• Funhoff EG, Salzmann J, Witholt B, van Beilen JB. Hydroxylation and epoxidation reactions catalyzed by CYP153 enzymes. Enzyme Microbial Technol 2007; 40: 806–812
   Google Scholar
• Gallo M, Bertrand JC, Azoulay E. Participation of cytochrome P450 in the oxidation of alkanes in Candida tropicalis. FEBS Lett 1971; 19: 45–49
   PubMed Web of Science ®Google Scholar
• Gilardi G, Meharenna YT, Tsotsou GE, Sadeghi SJ, Fairhead M, Giannini S. Molecular Lego: Design of molecular assemblies of P450 enzymes for nanobiotechnology. Biosens Bioelectron 2002; 17: 133–145
   PubMed Web of Science ®Google Scholar
• Gillam EMJ. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: Evolving designer catalysts from polyfunctional cytochrome P450 enzymes. Clin Exp Pharmacol Physiol 2005; 32: 147–152
   PubMed Web of Science ®Google Scholar
• Glieder A, Farinas ET, Arnold FH. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nature Biotechnol 2002; 20: 1135–1139
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Cytochrome P450: What have we learned and what are the future issues?. Drug Metabol Rev 2004; 36: 159–197
   PubMed Web of Science ®Google Scholar
• Gustafsson MCU, Roitel O, Marshall KR, Noble MA, Chapman SK, Pessegueiro A, Fulco AJ, Cheesman MR, von Wachenfeldt C, Munro AW. Expression, purification, and characterization of Bacillus subtilis cytochromes P450CYP102A2 and CYP102A3: Flavocytochrome homologues of P450BM3 from Bacillus megaterium. Biochemistry 2004; 43: 5474–5487
   PubMed Web of Science ®Google Scholar
• Harford Cross CF, Carmichael AB, Allan FK, England PA, Rouch DA, Wong LL. Protein engineering of cytochrome P450cam (CYP101) for the oxidation of polycyclic aromatic hydrocarbons. Prot Eng 2000; 13: 121–128
   PubMedGoogle Scholar
• Hollmann F, Hofstetter K, Schmid A. Non-enzymatic regeneration of nicotinamide and flavin cofactors for monooxygenase catalysis. Trends Biotechnol 2006; 24: 163–171
   PubMedGoogle Scholar
• Jones JP, O'Hare EJ, Wong LL. Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450cam). Eur J Biochem 2001; 268: 1460–1467
   PubMedGoogle Scholar
• Kubo T, Peters MW, Meinhold P, Arnold FH. Enantioselective epoxidation of terminal alkenes to (R)- and (S)-epoxides by engineered cytochromes P450BM-3. Chem Eur J 2006; 12: 1216–1220
   PubMed Web of Science ®Google Scholar
• Kubota M, Nodate M, Yasumoto-Hirose M, Uchiyama T, Kagami O, Shizuri Y, Misawa N. Isolation and functional analysis of Cytochrome P450 CYP153A genes from various environments. Biosci Biotechnol Biochem 2005; 69: 2421–2430
   PubMed Web of Science ®Google Scholar
• Landwehr M, Hochrein L, Otey CR, Kasrayan A, Baeckvall J-E, Arnold FH. Enantioselective α-hydroxylation of 2-arylacetic acid derivatives and Buspirone catalyzed by engineered Cytochrome P450 BM-3. J Am Chem Soc 2006; 128: 6058–6059
   PubMed Web of Science ®Google Scholar
• Lentz O, Urlacher V, Schmid RD. Substrate specificity of native and mutated cytochrome P450 (CYP102A3) from Bacillus subtilis. J Biotechnol 2004; 108: 41–49
   PubMed Web of Science ®Google Scholar
• Lentz O, Feenstra A, Habicher T, Hauer B, Schmid RD, Urlacher VB. Altering the regioselectivity of cytochrome P450 CYP102A3 of Bacillus subtilis by using a new versatile assay system. Chembiochem 2006; 7: 345–350
   PubMed Web of Science ®Google Scholar
• Lewis DFV, Lake BG, Dickins M. Substrates of human cytochromes P450 from families CYP1 and CYP2: Analysis of enzyme selectivity and metabolism. Drug Metabol Drug Interact 2004; 20: 111–142
   PubMedGoogle Scholar
• Li Q-S, Ogawa J, Schmid RD, Shimizu S. Indole hydroxylation by bacterial cytochrome P450 BM-3 and modulation of activity by cumene hydroperoxide. Biosci Biotechnol Biochem 2005; 69: 293–300
   PubMed Web of Science ®Google Scholar
• Li Z, Chang DL. Recent advances in regio- and stereoselective biohydroxylation of non-activated carbon atoms. Curr Org Chem 2004; 8: 1647–1658
   Google Scholar
• Li Z, Feiten H-J, Van Beilen JB, Duetz W, Witholt B. Preparation of optically active N-benzyl-3-hydroxypyrrolidine by enzymic hydroxylation. Tetrahed Asymm 1999; 10: 1323–1333
   Google Scholar
• Maier T, Foerster H-H, Asperger O, Hahn U. Molecular characterization of the 56-kDa CYP153 from Acinetobacter sp. EB104. Biochem Biophys Res Commun 2001; 286: 652–658
   PubMed Web of Science ®Google Scholar
• Matsuura K, Tosha T, Yoshioka S, Takahashi S, Ishimori K, Morishima I. Structural and functional characterization of ‘laboratory evolved’ cytochrome P450cam mutants showing enhanced naphthalene oxygenation activity. Biochem Biophys Res Commun 2004; 323: 1209–1215
   PubMedGoogle Scholar
• Meinhold P, Peters MW, Chen MMY, Takahashi K, Arnold FH. Direct conversion of ethane to ethanol by engineered cytochrome P450 BM3. Chembiochem 2005; 6: 1765–1768
   PubMed Web of Science ®Google Scholar
• Meinhold P, Peters MW, Hartwick A, Hernandez AR, Arnold FH. Engineering cytochrome P450 BM3 for terminal alkane hydroxylation. Adv Synth Cat 2006; 348: 763–772
   Web of Science ®Google Scholar
• Muenzer DF, Meinhold P, Peters MW, Feichtenhofer S, Griengl H, Arnold FH, Glieder A, de Raadt A. Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3. Chem Commun 2005; 2005: 2597–2599
   Google Scholar
• Müller R, Asperger O, Kleber HP. Purification of cytochrome P-450 from n-hexadecane-grown Acinetobacter calcoaceticus. Biomed Biochem Acta 1989; 48: 243–254
   PubMedGoogle Scholar
• Nakagawa T, Sawada M, Gonzalez FJ, Yokoi T, Kamataki T. Stable expression of human CYP2E1 in Chinese hamster cells: High sensitivity to N,N-dimethylnitrosamine in cytotoxicity testing. Mutat Res 1996; 360: 181–186
   PubMedGoogle Scholar
• Otey CR, Bandara G, Lalonde J, Takahashi K, Arnold FH. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. Biotechnol Bioeng 2006; 93: 494–499
   PubMed Web of Science ®Google Scholar
• Rettie AE, Sheffels PR, Korzekwa KR, Gonzalez FJ, Philpot RM, Baillie TA. CYP4 isozyme specificity and the relationship between ω-hydroxylation and terminal desaturation of valproic acid. Biochemistry 1995; 34: 7889–7895
   PubMed Web of Science ®Google Scholar
• Scheller U, Zimmer T, Kaergel E, Schunck W-H. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4. Arch Biochem Biophys 1996; 328: 245–254
   PubMedGoogle Scholar
• Scheller U, Zimmer T, Becher D, Schauer F, Schunck W-H. Oxygenation cascade in conversion of n-alkanes to α,ω-dioic acids catalyzed by cytochrome P450 52A3. J Biol Chem 1998; 273: 32528–32534
   PubMed Web of Science ®Google Scholar
• Sibbesen O, Zhang Z, Ortiz De Montellano PR. Cytochrome P450cam substrate specificity: Relationship between structure and catalytic oxidation of alkylbenzenes. Arch Biochem Biophys 1998; 353: 285–296
   PubMedGoogle Scholar
• Smits THM, Seeger MA, Witholt B, van Beilen JB. New alkane-responsive expression vectors for Escherichia coli and Pseudomonas. Plasmid 2001; 46: 16–24
   PubMedGoogle Scholar
• Smits THM, Balada SB, Witholt B, van Beilen JB. Functional analysis of alkane hydroxylases from Gram-negative and Gram-positive bacteria. J Bacteriol 2002; 184: 1733–1742
   PubMed Web of Science ®Google Scholar
• Sowden RJ, Yasmin S, Rees NH, Bell SG, Wong L-L. Biotransformation of the sesquiterpene (+)-valencene by cytochrome P450cam and P450BM-3. Org Biomol Chem 2005; 3: 57–64
   PubMed Web of Science ®Google Scholar
• Stevenson J-A, Westlake ACG, Whittock C, Wong L-L. The catalytic oxidation of linear and branched alkanes by Cytochrome P450cam. J Am Chem Soc 1996; 118: 12846–12847
   Google Scholar
• Sulistyaningdyah WT, Ogawa J, Li Q-S, Maeda C, Yano Y, Schmid RD, Shimizu S. Hydroxylation activity of P450 BM-3 mutant F87V towards aromatic compounds and its application to the synthesis of hydroquinone derivatives from phenolic compounds. Appl Microbiol Biotechnol 2005; 67: 556–562
   PubMedGoogle Scholar
• Urlacher VB, Lutz-Wahl S, Schmid RD. Microbial P450 enzymes in biotechnology. Appl Microbiol Biotechnol 2004; 64: 317–325
   PubMed Web of Science ®Google Scholar
• Urlacher VB, Makhsumkhanov A, Schmid RD. Biotransformation of β-ionone by engineered cytochrome P450 BM-3. Appl Microbiol Biotechnol 2006; 70: 53–59
   PubMedGoogle Scholar
• van Beilen JB, Funhoff EG. Expanding the alkane oxygenase toolbox: New enzymes and applications. Curr Opin Biotech 2005; 16: 308–314
   PubMed Web of Science ®Google Scholar
• van Beilen JB, Holtackers R, Luescher D, Bauer U, Witholt B, Duetz WA. Biocatalytic production of perillyl alcohol from limonene by using a novel Mycobacterium sp. Cytochrome P450 alkane hydroxylase expressed in Pseudomonas putida. Appl Environ Microbiol 2005a; 71: 1737–1744
   PubMed Web of Science ®Google Scholar
• van Beilen JB, Smits THM, Balada SB, Roos F, Brunner T, Witholt B. Identification of an amino acid position that determines the substrate range of integral-membrane alkane hydroxylases. J Bacteriol 2005b; 187: 85–91
   PubMedGoogle Scholar
• van Beilen JB, Funhoff EG, van Loon A, Just A, Kaysser L, Bouza M, Holtackers R, Rothlisberger M, Li Z, Witholt B. Cytochrome P450 alkane hydroxylases of the CYP153 family are common in alkane-degrading eubacteria lacking integral membrane alkane hydroxylases. Appl Environ Microbiol 2006a; 72: 59–65
   PubMed Web of Science ®Google Scholar
• van Beilen JB, Li Z, Duetz WA, Smits THM, Plaggemeier T, Witholt B, Engesser K-H. 2006b. Hexane-degrading bacteria isolated from a trickling-bed bioreactor contain integral-membrane non-heme iron as well as soluble cytochrome P450 alkane hydroxylases. Submitted.
   Google Scholar
• Warman AJ, Roitel O, Neeli R, Girvan HM, Seward HE, Murray SA, McLean KJ, Joyce MG, Toogood H, Holt RA, et al. Flavocytochrome P 450 BM3: An update on structure and mechanism of a biotechnologically important enzyme. Biochem Soc Trans 2005; 33: 747–753
   PubMedGoogle Scholar
• Xu F, Bell S, Lednik J, Insley A, Rao Z, Wong L. The heme monooxygenase Cytochrome P450(cam) can be engineered to oxidize ethane to ethanol. Angew Chem 2005; 44: 4029–4032
   Google Scholar
• Yadav JS, Loper JC. Multiple P450alk (cytochrome P450 alkane hydroxylase) genes from the halotolerant yeast Debaryomyces hansenii. Gene 1999; 226: 139–146
   PubMedGoogle Scholar
• Zimmer T, Ohkuma M, Ohta A, Takagi M, Schunck W-H. The CYP52 multigene family of Candida maltosa encodes functionally diverse n-alkane-inducible cytochromes P450. Biochem Biophys Res Commun 1996; 224: 784–789
   PubMedGoogle Scholar